AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3856293
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg PGE2
Trial: 8449431
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg PGE2
Trial: 8449431
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg PGE2
Trial: 28238742
Drug: Steroids (including
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids (including clobetasol)
Trial: 11258331
Drug: Preoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative administration of Vazaprostan‐20 into the pulmonary artery
Trial: 8059746
Drug: Oral irrigation
RxNorm normalized name: Irrigation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral irrigation with automatic toothbrush (n = 16)
Trial: 8059746
Drug: Oral irrigation
RxNorm normalized name: Irrigation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral irrigation with manual toothbrushing (n = 16)
Trial: 3133716
Drug: Trazodone 150
RxNorm normalized name: traZODone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone 150 mg nocte
Trial: 3133716
Drug: Mianserin 30
RxNorm normalized name: mianserin 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin 30 mg nocte for 7 days, then 60 mg nocte for 5 weeks
Trial: 3133716
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Trazodone and Mianserin)
Trial: 15111846
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg once a day for 45 days
Trial: 15556053
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose aspirin (≤125 mg daily)
Trial: 1491774
Drug: Fluconazole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (150 mg single oral administration)
Trial: 1491774
Drug: Ketoconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200 mg capsules daily for 5 days)
Trial: 3100311
Drug: Aluminium containing
RxNorm normalized name: Aluminium
DrugBank: Aluminium phosphate (DB14517)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aluminium containing antacids (1, 4, or 8 tablets, 244 mg aluminium per tablet) taken with citric acid solution
Trial: 3100311
Drug: Aluminium containing
RxNorm normalized name: Aluminium
DrugBank: Aluminium phosphate (DB14517)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aluminium containing antacids (1, 4, or 8 tablets, 244 mg aluminium per tablet) taken with orange juice
Trial: 3100311
Drug: Aluminium containing
RxNorm normalized name: Aluminium
DrugBank: Aluminium phosphate (DB14517)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aluminium containing antacids (4 tablets) taken with water
Trial: 3100311
Drug: Aluminium containing
RxNorm normalized name: Aluminium
DrugBank: Aluminium phosphate (DB14517)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aluminium containing antacids (1, 4, or 8 tablets) taken with water
Trial: 3100311
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of aluminium containing antacids
Trial: 3100311
Drug: Aluminium containing
RxNorm normalized name: Aluminium
DrugBank: Aluminium phosphate (DB14517)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aluminium containing antacids taken with orange juice or citric acid
Trial: 26814280
Drug: Daily morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily morphine (n=11)
Trial: 22908326
Drug: Anti-TNF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF therapy (SpA patients)
Trial: 22908326
Drug: Anti-TNF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF therapy (mAbs)
Trial: 22908326
Drug: Etanercept (Anti-TNF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (Anti-TNF therapy)
Trial: 22908326
Drug: Older age
RxNorm normalized name: AGS-499
DrugBank: AGS-499 (DB18058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older age and mAb treatment
Trial: 20492876
Drug: Intermittent etanercept
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intermittent etanercept therapy
Trial: 18639771
Drug: Ezetimibe-based therapy
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe-based therapy
Trial: 8600096
Drug: AK-2123 (880
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AK-2123 (880 mg) with discontinuous accelerated hyperfractionated radiation
Trial: 8600096
Drug: AK-2123 (990
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AK-2123 (990 mg) with discontinuous accelerated hyperfractionated radiation
Trial: 6817123
Drug: Captopril after
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril after diuretic (thiazide) pretreatment
Trial: 6817123
Drug: Captopril without
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril without diuretic (thiazide) pretreatment
Trial: 30105808
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (couple therapy other than EFT)
Trial: 30674586
Drug: Inhaled saline
RxNorm normalized name: Broncho Saline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled saline
Trial: 23758233
Drug: On-demand inhalation
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand inhalation
Trial: 23758233
Drug: Fixed-schedule inhalation
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-schedule inhalation
Trial: 19249410
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g daily of omega‐3‐acid ethyl esters
Trial: 17288648
Drug: Exposure-based and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure-based and cognitive restructuring therapy
Trial: 16279283
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of folic acid, vitamin B6, and vitamin B12
Trial: 12390056
Drug: Tocopherol 400
RxNorm normalized name: alpha-tocopherol 400 UNT / ubidecarenone 200 MG Oral Wafer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocopherol 400 IU daily
Trial: 12390056
Drug: Pravastatin 20
RxNorm normalized name: pravastatin 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 20 mg daily plus tocopherol 400 IU daily
Trial: 9836032
Drug: Rocuronium (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.6 mg.kg‐1; n = 20)
Trial: 9836032
Drug: Atracurium (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (0.5 mg.kg‐1; n = 21)
Trial: 6180050
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of human fibroblast-derived (beta) interferon (HulFN-beta) at a total of 1-2 x 10(5) reference units per day, divided into 8-10 drops.
Trial: 6180050
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of human fibroblast-derived (beta) interferon (HulFN-beta)
Trial: 6180050
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy or placebo containing human serum albumin, with the same administration schedule.
Trial: 6180050
Drug: Doses of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doses of interferon lower than 5 x 10(4) units per day
Trial: 29362205
Drug: Video with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video with drug risk information
Trial: 29362205
Drug: Video without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Video without drug risk information
Trial: 15860855
Drug: Adjuvant anthracycline-based
RxNorm normalized name: Rna-based adjuvant cv8102
DrugBank: CV-8102 (DB19184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant anthracycline-based chemotherapy
Trial: 12619921
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 2.5 U/day
Trial: 12619921
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 1.0 U/day
Trial: 8471372
Drug: Diclofenac 150
RxNorm normalized name: diclofenac sodium 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 150 mg/24 h
Trial: 8471372
Drug: Ketoprofen 200
RxNorm normalized name: ketoprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 200 mg/24 h
Trial: 28589894
Drug: Antenatal expressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal expressing (expressing breastmilk twice per day from 36 weeks' gestation)
Trial: 23359491
Drug: Mericitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mericitabine 1,000 mg BID plus Peg‐IFNα‐2a/RBV
Trial: 9093678
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HIT and HSN
Trial: 8203844
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg daily for 3 days (multiple-dose administration)
Trial: 8203844
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg as a single dose (single-dose administration)
Trial: 8203844
Drug: Fleroxacin administered
RxNorm normalized name: fleroxacin
DrugBank: Fleroxacin (DB04576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin administered in a fed state
Trial: 31338868
Drug: Liraglutide (1.2-1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (1.2-1.8 mg/d for 26 weeks)
Trial: 28982906
Drug: GA with
RxNorm normalized name: Tums with Gas Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA with single-injection thoracic paravertebral block (s-TPVB)
Trial: 25028082
Drug: 10-g milk-LNS
RxNorm normalized name: Milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-g milk-LNS
Trial: 25028082
Drug: 20-g milk-LNS
RxNorm normalized name: Milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-g milk-LNS
Trial: 25028082
Drug: 20-g non-milk-LNS
RxNorm normalized name: Milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-g non-milk-LNS
Trial: 25028082
Drug: 40-g milk-LNS
RxNorm normalized name: Milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-g milk-LNS
Trial: 25028082
Drug: 40-g non-milk-LNS
RxNorm normalized name: Milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-g non-milk-LNS
Trial: 23456732
Drug: ATV400 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATV400 (400 mg once daily)
Trial: 23456732
Drug: ATV300/r (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATV300/r (300 mg ATV plus 100 mg ritonavir once daily)
Trial: 20817749
Drug: THC (4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC (4, 6, and 6 mg, vaporized and inhaled)
Trial: 20817749
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of MDMA and THC
Trial: 9589229
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml of water with 25 g glucose
Trial: 9589229
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of water with 25 g glucose
Trial: 9589229
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml of water with 25 g sucrose
Trial: 9589229
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of water with 25 g sucrose
Trial: 9589229
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml of water with 25 g fructose
Trial: 9589229
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of water with 25 g fructose
Trial: 2648791
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (group 1)
Trial: 27620550
Drug: Lipopolysaccharide (LPS)
RxNorm normalized name: sulfated mucopolysaccharides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipopolysaccharide (LPS) administration at a dose of 2 ng/kg
Trial: 24131168
Drug: Saline (placebo)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (placebo) administration
Trial: 21735655
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg tramadol hydrochloride with behavioral modification
Trial: 21735655
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy only
Trial: 11207994
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide inhalation therapy
Trial: 19433387
Drug: Up-front zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Up-front zoledronic acid (ZA; 4 mg intravenously every 6 months)
Trial: 19433387
Drug: Delayed-start zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Delayed-start zoledronic acid (ZA; 4 mg intravenously every 6 months)
Trial: 16904446
Drug: Tolterodine extended
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine extended release (TER) 4 mg daily
Trial: 14698800
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg buprenorphine per day
Trial: 14698800
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg buprenorphine per day
Trial: 7824150
Drug: Low-dose nitroglycerin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nitroglycerin (5-20 micrograms/minute)
Trial: 7824150
Drug: High-dose nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nitroglycerin (80-240 micrograms/minute)
Trial: 3415015
Drug: N2O (70%)
RxNorm normalized name: N2O
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N2O (70%) and fentanyl (10 micrograms/kg iv bolus followed by 4 micrograms.kg‐1.h‐1 infusion) with additional warming (humidified respiratory gases, warmed intravenous fluids, and a heating blanket over the legs; n = 5)
Trial: 3415015
Drug: N2O (70%)
RxNorm normalized name: N2O
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N2O (70%) and fentanyl (10 micrograms/kg iv bolus followed by 4 micrograms.kg‐1.h‐1 infusion) with standard temperature management (no special warming measures; n = 10)
Trial: 21091898
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g phenacetin (single oral dose)
Trial: 18208572
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg capsule of aprepitant
Trial: 18208572
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg capsule of aprepitant
Trial: 16772708
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) 12,000 U twice/month for 6 months
Trial: 14634405
Drug: 5 cc
RxNorm normalized name: Syringe Unit 35 cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 cc saline
Trial: 14634405
Drug: 2.5 cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 cc 1% lidocaine (bilateral basal injection)
Trial: 14634405
Drug: 5 cc
RxNorm normalized name: Syringe Unit 35 cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 cc 1% lidocaine
Trial: 14634405
Drug: 10 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 cc 1% lidocaine
Trial: 14634405
Drug: 10 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 cc 1% lidocaine (bilateral basal plus apical injections)
Trial: 10952826
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with normal glucose and insulin levels
Trial: 30522550
Drug: Propylthiouracil, Jelfa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propylthiouracil, Jelfa tablets
Trial: 30522550
Drug: Propycil tablets
RxNorm normalized name: Propyl Gallate
DrugBank: Propyl Gallate (DB12450)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propycil tablets
Trial: 23635626
Drug: Combination (Metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (Metoclopramide 10 mg + Ondansetron 4 mg)
Trial: 8973669
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (randomized group)
Trial: 1434877
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (medical treatment)
Trial: 6477250
Drug: Retrobulbar injection
RxNorm normalized name: LIDOCAINE HYDROCHLORIDE 40 mg in 1 mL RETROBULBAR INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrobulbar injection of 2% mepivacaine hydrochloride (with hyaluronidase added in 12 patients)
Trial: 24300901
Drug: Perceived neighborhood
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perceived neighborhood drug involvement
Trial: 22405251
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin plus prednisolone (2 mg/kg per day for 15 days after C-reactive protein normalised)
Trial: 22405251
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (2 g/kg for 24 h and aspirin 30 mg/kg per day)
Trial: 18679597
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment group (Jieze No.1 + Azithromycin)
Trial: 16291411
Drug: Glimepiride 2
RxNorm normalized name: glimepiride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride 2 mg QD plus Metformin 500 mg TID (G + M)
Trial: 16291411
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg QD plus Metformin 500 mg TID (R + M)
Trial: 10424932
Drug: Intravenous thrombolytic
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolytic therapy using tissue plasminogen activator (tPA) at a dose of 0.9 mg/kg body weight.
Trial: 10424932
Drug: Streptokinase therapy.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase therapy.
Trial: 10424932
Drug: Ancrod therapy
RxNorm normalized name: ancrod
DrugBank: Ancrod (DB05099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ancrod therapy (STAT study).
Trial: 10424932
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (general).
Trial: 2112180
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (IV STK)
Trial: 2112180
Drug: Intravenous tissue
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue plasminogen (IV TPA)
Trial: 1270971
Drug: Ethanol (133.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (133.7 g)
Trial: 29173606
Drug: High ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High ticagrelor loading dose (360 mg)
Trial: 29173606
Drug: Conventional ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional ticagrelor loading dose (180 mg)
Trial: 16495695
Drug: Percutaneous local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous local ablative therapy (PLAT)
Trial: 8248660
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitors (specific types not mentioned)
Trial: 31573387
Drug: Insoluble yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insoluble yeast β‐glucan (250 mg, 250 mL/day)
Trial: 31573387
Drug: Soluble yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble yeast β‐glucan (250 mg, 250 mL/day)